VYCO — VYCOR MEDICAL INC

OTC · Health Care · Health Care Equipment & Supplies · CIK 1424768 ·
Last close
Market Cap
52W High
52W Low
ADV30
Next earnings
Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. The company operates through two segments: Vycor Medical and NovaVision. Its Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation therapies targeted at people who have impaired vision as a result of stroke or other brain injury. It has a license agreement with a German-based partner. It primarily serves hospitals and medical professionals. The company was incorporated in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. operates as a subsidiary of Fountainhead Capital Management Ltd.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 458,540 375,153 45,808 20,108 854,071 173,634 5,083,027
Dec 2025 416,877 335,370 -36,525 -62,686 830,420 86,982 4,917,299
Sep 2025 513,792 451,932 32,085 4,936 941,195 64,230 4,965,388
Jun 2025 496,353 415,271 51,146 23,887 878,946 99,700 4,745,890

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-14,107
Investing CF
$-4,383
Financing CF
$-812
CapEx
$-1,606
Dividends Paid
Buybacks
EPS Diluted TTM
$-0.02
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-33,648,856
Inventory
$159,202
Receivables
$218,891
ST Investments
EBIT TTM
$33,392
Pretax Income TTM
$-70,190
Interest Exp TTM
$103,582
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,885,562
EBITDA
$155,215
Free Cash Flow
$441,862
Enterprise Value
$3,139,963
Total Cash
$173,634
Total Debt
$980,812
Shares Out
33,372,796
Trailing EPS
$0.00
Book Value
$-0.12
ROE
ROA
6.4%
Div Yield

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 1,863,400 33,900 -72,426 830,420 4,917,299 -13,471
Dec 2024 1,589,324 -9,145 -107,200 998,117 4,688,200 60,110
Dec 2023 1,460,604 40,191 -69,691 992,298 4,317,774 29,430
Dec 2022 1,222,989 -306,514 -404,917 860,178 3,801,049 -217,016
Dec 2021

Peers — same industry

TickerNameMarket CapLastDaily %
ISRG INTUITIVE SURGICAL INC $154.64B $436.64
SYK STRYKER CORP $119.99B $313.00
MDT Medtronic plc $99.63B $77.60
BSX BOSTON SCIENTIFIC CORP $85.67B $57.64
MMM 3M CO $80.34B $154.03

News headlines (Yahoo Finance, 1h cache)

Vycor Medical Releases Financial Results for the Three Months Ended March 31, 2026
2026-05-15 19:01 · Yahoo
Vycor Medical Releases Financial Results for the Year Ended December 31, 2025
2026-03-31 18:53 · Yahoo
Vycor Medical Releases Financial Results for the Three and Nine Months Ended September 30, 2025
2025-11-14 15:45 · Yahoo
Vycor Medical Releases Financial Results for the Three and Six Months Ended June 30, 2025
2025-08-08 16:27 · Yahoo
New Study on NovaVision's NeuroEyeCoach Shows Significant Benefits for Patients in Home or Clinic Setting
2025-07-08 12:30 · Yahoo
Life Sciences Investor Forum: Now Available for Online Viewing
2025-06-13 12:35 · Yahoo
Life Sciences Investor Forum Agenda Announced for June 11th-12th
2025-06-10 18:38 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.